Everolimus Implicated in Case of Severe Gastrointestinal Hemorrhage
Breast cancer remains the leading cause of cancer and the third leading cause of cancer related deaths among our population with an estimated number of 246,660 new cases and 40,450 deaths in 2016. With treatment advancements, including targeted agents such as Everolimus, a mammalian target of rapamy...
Saved in:
Main Authors: | Paul Gonzales, Seth Klusewitz, Johanna Marowske, John Gancayco, Michael B. Osswald, Robert Setlik |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Case Reports in Oncological Medicine |
Online Access: | http://dx.doi.org/10.1155/2017/3657812 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Everolimus in Heart Transplantation: An Update
by: Stephan W. Hirt, et al.
Published: (2013-01-01) -
Severe Gastrointestinal Hemorrhage due to Monkeypox Virus-Associated Proctocolitis
by: Sobaan Taj, et al.
Published: (2023-01-01) -
Stent Fracture after Everolimus-Eluting Stent Implantation
by: Ali S. Almasood, et al.
Published: (2011-01-01) -
Everolimus for Compassionate Use in Multiple Basal Cell Carcinomas
by: Laura Eibenschutz, et al.
Published: (2013-01-01) -
Midterm Clinical Impacts of Biodegradable Polymer Everolimus-Eluting Stents Compared with Durable Polymer Everolimus-Eluting Stents: A 3-Year Propensity-Matched Study
by: Hiroaki Matsuda, et al.
Published: (2020-01-01)